Image alt tag

Error!

There was a problem contacting the server. Please try after sometime.

Sorry, we are unable to process your request.

Error!

We're sorry, but the Insights and Intelligence Tool is temporarily unavailable

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Error!

We're sorry, but the Literature Center checkout function is temporarily unavailable.

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

Reset Your Password

Financial Professionals*

Your password must be a minimum of characters.

Confirmation Message

Your LordAbbett.com password was successully updated. This page will be refreshed after 3 seconds.

OK

 

Dividend Growth Fund

Summary

Summary

What is the Dividend Growth Fund?

The Fund seeks to deliver total return by investing primarily in stocks of large U.S. companies that have a history of increasing their dividends.

HIGH-QUALITY UNIVERSE

Companies with consistent dividend growth are often market leaders with stable business models, strong balance sheets, and management teams committed to shareholders.

LOWER RISK PROFILE

Focusing on U.S. companies that have consistently grown their dividends often provides investors with an equity portfolio that has a lower risk profile than the broader market.

GROWTH AND RISING INCOME

A portfolio of consistent dividend growers may provide investors with long-term growth and rising income. Many of these companies have grown their dividends much faster than inflation.

Fund Basicsas of 02/28/2020

Total Net Assets
$2.35 B
Inception Date
12/27/2001
Dividend Frequency
Quarterly
Number of Holdings
66
Minimum Initial Investment
$1,000+

Expense Ratioas of 02/29/2020

Yield

12-Month Dividend Yield 1 as of 04/01/2020  

w/o sales charge 1.91%
w/ sales charge 1.80%

30-Day Standardized Yield 2 as of 02/29/2020  

1.26%

Fund Expense Ratio :

0.95%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 12/27/2001
w/o sales charge -19.86% -9.38% 3.31% 5.31% 8.60% 7.01%
Lipper Category Avg. Equity Income Funds - - - - - -
S&P 500 Index -19.60% -6.98% 5.10% 6.73% 10.53% 6.63%
w/ sales charge -24.48% -14.57% 1.29% 4.07% 7.96% 6.66%

Fund Expense Ratio :

0.95%

Fund Expense Ratio :

0.95%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 12/27/2001
w/o sales charge -19.86% -9.38% 3.31% 5.31% 8.60% 7.01%
Lipper Category Avg. Equity Income Funds - - - - - -
S&P 500 Index -19.60% -6.98% 5.10% 6.73% 10.53% 6.63%
w/ sales charge -24.48% -14.57% 1.29% 4.07% 7.96% 6.66%

Fund Expense Ratio :

0.95%

RELATED CONTENT

Finding Durability in U.S. Growth Stocks
February 24, 2020

For investors still concerned with equity volatility, focusing on durable franchises may provide an incentive to stay invested in growth stocks.

Our Guide to Dividend Income, in Two Charts
January 27, 2020

Instead of focusing on current yield, investors may be better served by considering the potential growth of dividend income over time.

Holdings as of 02/28/2020View Portfolio

Holding Assets
Microsoft Corp. 4.6%
Abbott Laboratories 2.7%
Procter & Gamble Co. 2.7%
Medtronic, Inc. 2.6%
Union Pacific Corp. 2.4%
Comcast Corp. 2.3%
PepsiCo, Inc. 2.3%
Verizon Communications, Inc. 2.3%
Analog Devices, Inc. 2.2%
AT&T, Inc. 2.1%
% of Total Assets 26.3%

INVESTMENT TEAM

Walter H. Prahl
Walter H. Prahl, Ph.D.

Partner & Director

34 Years of Industry Experience

Marc O. Pavese
Marc O. Pavese, Ph.D.

Partner & Portfolio Manager

19 Years of Industry Experience

Darnell Azeez
Darnell Azeez, CFA

Portfolio Manager

17 Years of Industry Experience

Servesh Tiwari
Servesh Tiwari, CFA

Portfolio Manager

13 Years of Industry Experience

Supported By 35 Investment Professionals with 18 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

12-Month Dividend Yield 1 as of 04/01/2020  

w/o sales charge 1.91%
w/ sales charge 1.80%

30-Day Standardized Yield 2 as of 02/29/2020  

  Subsidized5 Un-Subsidized6
w/o sales charge 1.26% 1.26%

Fund Expense Ratio :

0.95%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 12/27/2001
w/o sales charge -19.86% -9.38% 3.31% 5.31% 8.60% 7.01%
Lipper Category Avg. Equity Income Funds - - - - - -
S&P 500 Index -19.60% -6.98% 5.10% 6.73% 10.53% 6.63%
w/ sales charge -24.48% -14.57% 1.29% 4.07% 7.96% 6.66%

Fund Expense Ratio :

0.95%

Fund Expense Ratio :

0.95%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 12/27/2001
w/o sales charge -19.86% -9.38% 3.31% 5.31% 8.60% 7.01%
Lipper Category Avg. Equity Income Funds - - - - - -
S&P 500 Index -19.60% -6.98% 5.10% 6.73% 10.53% 6.63%
w/ sales charge -24.48% -14.57% 1.29% 4.07% 7.96% 6.66%

Fund Expense Ratio :

0.95%

Year Fund Returns S&P 500 Index
2019 26.58% 31.49%
2018 -4.73% -4.38%
2017 19.09% 21.83%
2016 15.13% 11.96%
2015 -2.38% 1.38%
2014 11.56% 13.69%
2013 27.96% 32.39%
2012 13.05% 16.00%
2011 -0.23% 2.11%
2010 14.81% 15.06%
2009 23.21% -
2008 -27.29% -
2007 3.03% -
2006 14.78% -
2005 3.65% -
2004 16.72% -
2003 21.79% -
2002 -7.68% -
2001 0.00% -
Year Q1 Q2 Q3 Q4 Yearly Returns
2020 -19.86% - - - -23.31%
2019 11.93% 3.96% 4.32% 4.27% 26.58%
2018 -2.75% 1.25% 8.40% -10.74% -4.73%
2017 4.37% 2.53% 3.38% 7.65% 19.09%
2016 6.06% 4.89% 0.76% 2.71% 15.13%
2015 -0.12% -2.21% -5.73% 6.01% -2.38%
2014 1.52% 4.69% -1.43% 6.50% 11.56%
2013 10.47% 1.27% 5.31% 8.61% 27.96%
2012 10.90% -3.82% 5.76% 0.22% 13.05%
2011 5.52% -0.22% -13.93% 10.10% -0.23%
2010 4.78% -8.15% 10.21% 8.24% 14.81%
2009 -5.29% 9.90% 12.47% 5.25% 23.21%
2008 -8.66% -0.42% -9.07% -12.09% -27.29%
2007 3.47% 4.17% -1.18% -3.26% 3.03%
2006 2.32% 0.64% 3.27% 7.93% 14.78%
2005 -1.04% 1.92% 2.63% 0.13% 3.65%
2004 3.53% 1.67% 1.96% 8.76% 16.72%
2003 -6.08% 11.96% 2.98% 12.47% 21.79%
2002 7.39% -5.36% -13.24% 4.70% -7.68%
2001 - - - - 0.00%

Growth of $10,000 as of 02/29/2020

NAV HISTORICAL PRICES

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioning as of 12/31/2019

  • Abbott Laboratories, a health care products manufacturer, is the portfolio’s largest overweight position relative to the portfolio’s benchmark, the S&P 500 Index, as of December 31, 2019. We believe the firm has demonstrated strong management execution, robust revenue growth, and that there is an opportunity to expand margins. The company has a robust pipeline in the medical device and diagnostic segments, which we believe will allow the company to maintain high revenue growth rates relative to its peers.
  • Medtronic, Inc., a device based medical therapy distributor, is another of the portfolio’s overweight positions relative to its benchmark. We believe the firm has a promising pipeline of medical devices and has consistently exhibited stable earnings, which makes the security an attractive long term prospect.
  • The portfolio also is overweight in Union Pacific Corp., a rail transportation company, relative to the benchmark. We believe that Union Pacific is attractive because of the expected implementation of the Precision Scheduled Railroading model, which is likely to result in further productivity gains.

PORTFOLIO DETAILS as of 02/28/2020

Total Net Assets
$2.35 B
Number of Holdings
66
Weighted Average Market Cap.
194.4 B
P/B Ratio
4.1x
P/E Ratio
21.5x

Contributors & Detractors as of  12/31/2019

Contributors

Holding Contribution
Microsoft Corp. 0.4%
Union Pacific Corp. 0.3%
Target Corp. 0.3%
Johnson & Johnson, Inc. 0.2%
Philip Morris International, Inc. 0.2%

Detractors

Holding Contribution
Hasbro, Inc. -0.2%
Northrop Grumman Corp. -0.1%
International Business Machines Corp. -0.1%
Travelers Cos, Inc. -0.1%
UGI Corp. -0.1%

Attribution Analysis 

Dividend Growth Fund Benchmark Variance
Sector Avg. Weight Base Return Avg. Weight Base Return Stock Selection Group Weight Total

Dividends & Cap Gains

Dividends & Cap Gains

Dividend Payments

For
YTD Dividends Paidas of 04/01/2020
$0.047
Dividend Frequency
Quarterly
Record Date Ex-Dividend Date Reinvest & Payable Date Dividend Reinvest Price
03/26/2020 03/27/2020 03/27/2020 $0.04750 $12.60

Upcoming Dividend Payment Dates

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date Reinvest & Payable Date
06/29/2020 06/30/2020 06/30/2020
09/28/2020 09/29/2020 09/29/2020
12/28/2020 12/29/2020 12/29/2020

Capital Gains Distributions

For
Record Date Reinvest & Payable Date Long-term Short-term * Total Reinvest Price
12/17/2019 12/18/2019 $0.6870 $0.0094 $0.6964 $15.93

Upcoming Capital Gain Distribution

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date
12/17/2020 12/18/2020

Fees & Expenses

Fees & Expenses

Sales Charge Schedule as of 04/01/2020

  Sales Charge Dealer's Concession Prices at Breakpoint
Less than $50,000 5.75% 5.00% $12.99
$50,000 to $99,999 4.75% 4.00% $12.85
$100,000 to $249,999 3.95% 3.25% $12.74
$250,000 to $499,999 2.75% 2.25% $12.59
$500,000 to $999,999 1.95% 1.75% $12.48
$1,000,000 to $5,000,000 0.00% 1.00% $12.24

EXPENSE RATIOas of 02/29/2020

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
n/a
Prospectus (XBRL)
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

Class A  Except as noted below, returns with sales charges reflect a maximum sales charge of 5.75% for equity funds, 2.25% for all tax-free income funds, fixed income funds and multi-asset class funds. There are also ongoing 12b-1 service fees (and, in certain cases, distribution fees).

Class A Shares purchased subject to a front-end sales charge have no contingent deferred sales charge (CDSC). However, certain purchases of Class A shares made without a front-end sales charge may be subject to a CDSC of 1% if the shares are redeemed before the first day of the month in which the one year anniversary of the purchase falls. The CDSC is not reflected in the performance with maximum sales charge.

Except as noted below, returns with sales charges reflect a maximum sales charge of 2.50%. There are also ongoing 12b-1 service and distribution fees.

Class A Shares purchased subject to a front-end sales charge have no contingent deferred sales charge (CDSC). However, certain purchases of Class A shares made without a front-end sales charge may be subject to a CDSC of 1.50% if the shares are repurchased before the first day of the month in which the one year anniversary of the purchase falls. The CDSC is not reflected in the performance with maximum sales charge.

 

Except as noted below, returns with sales charges reflect a maximum sales charge of 2.50%. There are also ongoing 12b-1 service and distribution fees.

Class A Shares purchased subject to a front-end sales charge have no contingent deferred sales charge (CDSC). However, certain purchases of Class A shares made without a front-end sales charge may be subject to a CDSC of 1.50% if the shares are repurchased before the first day of the month in which the one year anniversary of the purchase falls. The CDSC is not reflected in the performance with maximum sales charge.

The S&P 500® Index is widely regarded as the standard for measuring large cap U.S. stock market performance and includes a representative sample of leading companies in leading industries.

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field